Status:
TERMINATED
Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Abdominal Adhesions
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will examine the safety and efficacy of Sepraspray in the following model of abdominal surgery: total proctocolectomy and pelvic pouch with diverting ileostomy via laparotomy to treat ulcer...
Eligibility Criteria
Inclusion
- Patients who are scheduled to undergo a total proctocolectomy and a pelvic pouch with diverting ileostomy.
Exclusion
- Patients who are pregnant.
- Patients with ongoing abdominal abscess.
- Patients with ongoing bacterial peritonitis.
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00665730
Start Date
July 1 2007
End Date
June 1 2008
Last Update
May 8 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Masarykova, Czechia
2
Prague, Czechia
3
Aarhus C, Denmark
4
Lille, France